Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers
- PMID: 8532072
- DOI: 10.1007/BF00172781
Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers
Abstract
Epinine (N-methyl-dopamine, the active metabolite of ibopamine), is a full agonist at dopamine (DA)-receptors and alpha- and beta-adrenoceptors. To study whether in vivo DA-receptors mediated effects can be separated from alpha- and beta-adrenoceptor effects we compared in 10 male volunteers the effects of i.v. epinine (0.5; 1; 2; 4 micrograms/kg/min for 15 min each) on DA-receptor (changes in serum prolactin)- and alpha- and beta-adrenoceptor (changes in systolic [Psyst] and diastolic blood pressure [Pdiast] and heart rate)-mediated effects with those of dopamine before and after propranolol (5 mg i.v. 45 min pre-infusion), bisoprolol (15 mg p.o. 2 h pre-infusion) and domperidone (10 mg p.o. 1 h pre-infusion). At the 0.5 and 1 microgram doses of dopamine and epinine did not effect Psyst, Pdiast and heart rate but significantly decreased prolactin levels. At the higher dose both dopamine and epinine significantly increased Psyst and heart rate, while only epinine significantly increased Pdiast. In addition, both dopamine and epinine significantly increased diuresis and natriuresis; in contrast, only dopamine, but not epinine dose-dependently increased plasma noradrenaline levels. Domperidone did not affect dopamine- and epinine-evoked blood pressure- and heart rate-changes, but antagonized their prolactin-effects (at least at the lower doses). Bisoprolol and propranolol significantly reduced dopamine-induced Psyst- and heart rate-increases to about the same extent. Propranolol enhanced epinine-induced Psyst- and Pdiast-increases while bisoprolol reduced epinine-evoked Psyst-increase but not Pdiast-increase. Epinine-induced heart rate-increase was abolished by bisoprolol and was converted into heart rate-decrease by propranolol. We concluded that in 0.5 and 1 microgram doses (plasma levels of 20-80 nmol/l)epinine acts only at DA-receptors. Thus, ibopamine in therapeutically recommended doses (3 x 100 mg/day with peak plasma epinine-levels of 50-80 nmol/l) very likely activates only DA-receptors. In higher doses, however, epinine-like dopamine-activates alpha- and beta-adrenoceptors whereby epinine has a stronger alpha-adrenoceptor agonistic activity than dopamine. Moreover, part of the dopamine-effects are indirect via release of endogenous noradrenaline whereas epinine-effects do not appear to include an indirect component.
Similar articles
-
Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade.Br J Pharmacol. 1992 Oct;107(2):303-10. doi: 10.1111/j.1476-5381.1992.tb12742.x. Br J Pharmacol. 1992. PMID: 1330172 Free PMC article.
-
Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine.Naunyn Schmiedebergs Arch Pharmacol. 1997 Feb;355(2):239-49. doi: 10.1007/pl00004938. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9050018 Clinical Trial.
-
Comparison of the cardiovascular actions of dopamine and epinine in the dog.J Pharmacol Exp Ther. 1985 Apr;233(1):87-93. J Pharmacol Exp Ther. 1985. PMID: 2858584
-
[Ibopamine--pharmacologic principles].Z Kardiol. 1991;80 Suppl 8:63-6. Z Kardiol. 1991. PMID: 1686693 Review. German.
-
Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.Cardiology. 1990;77 Suppl 5:22-9. doi: 10.1159/000174692. Cardiology. 1990. PMID: 1980631 Review.
Cited by
-
Dopamine D2 receptor upregulates leptin and IL-6 in adipocytes.J Lipid Res. 2018 Apr;59(4):607-614. doi: 10.1194/jlr.M081000. Epub 2018 Feb 22. J Lipid Res. 2018. PMID: 29472382 Free PMC article.
-
Losartan reduces mortality in a genetic model of heart failure.Naunyn Schmiedebergs Arch Pharmacol. 2010 Sep;382(3):265-78. doi: 10.1007/s00210-010-0544-3. Epub 2010 Aug 10. Naunyn Schmiedebergs Arch Pharmacol. 2010. PMID: 20697885